Musashino-shi, Tokyo, Japan Clinical Trials

A listing of Musashino-shi, Tokyo, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 414 clinical trials
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against Crohn's disease or ulcerative colitis under actual status of use.

biosimilar
infliximab
colitis
ulcerative colitis
crohn's disease
Pfizer Local Country Office
 (5.5 away) Contact site
  • 8 views
  • 29 Jan, 2021
  • 1 location
Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.

Japan Community Health care Organization Tokyo Yamate Medical Center /ID# 214134
 (7.4 away) Contact site
  • 43 views
  • 19 Aug, 2021
  • +38 other locations
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against rheumatoid arthritis under actual status of use.

methotrexate
infliximab
Pfizer Local Country Office
 (5.5 away) Contact site
  • 1 views
  • 23 Jan, 2021
  • 1 location
Vyndaqel Capsules Special Investigation (ATTR-CM)

Secondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan.

Pfizer
 (5.5 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • 1 location
Survey Study for Velaglucerase Alfa (VPRIV) in Japan

The objective of this post-marketing survey study is to collect data to determine the safety and efficacy of velaglucerase alfa (VPRIV) in participants with Gaucher disease who are new to therapy or have been switched from another therapeutic agent for Gaucher disease.

velaglucerase alfa
vpriv
Tokorozawa
 (8.1 away) Contact site
  • 74 views
  • 27 Jan, 2021
  • +30 other locations
BOTOX Drug Use Investigation (Spasmodic Dysphonia)

This study is a drug use investigation program of BOTOX. The objective of this investigation is to collect and assess information on the safety and efficacy of BOTOX injections in subjects with a diagnosis of spasmodic dysphonia in daily clinical practice. All subjects treated with BOTOX for spasmodic dysphonia after …

GSK Investigational Site
 (9.9 away) Contact site
  • 13 views
  • 23 Jan, 2021
  • 1 location
Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

The purpose of this survey is to monitor and identify the occurrence of neutropenia and febrile neutropenia in untreated CD30-positive Hodgkin's lymphoma participants on concomitant brentuximab vedotin and doxorubicin hydrochloride, vinblastine sulfate, and dacarbazine (AVD) in routine clinical practice.

Takeda Selected Site
 (5.5 away) Contact site
  • 1 views
  • 01 Apr, 2021
  • 1 location
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

The purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.

Takeda Selected Site
 (7.3 away) Contact site
  • 17 views
  • 27 Jan, 2021
  • 1 location
ADYNOVATE Drug Use-Results Survey

The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients: Unexpected adverse drug reactions Occurrence of adverse drug reactions in the actual clinical use Factors that may affect safety and efficacy Occurrence of Factor VIII inhibitor development in patients with …

deficiency
antihemophilic factor
coagulation factor
adynovate
factor viii inhibitor
Suginami-ku, Japan
 (2.2 away) Contact site
  • 132 views
  • 26 Jan, 2021
  • +48 other locations
A Study of the Safety Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

This study will assess the safety and effectiveness of Maviret (Glecaprevir plus Pibrentasvir (GLE/PIB)) in adolescent participants diagnosed with chronic hepatitis C (CHC) in a real world setting across clinical practice in Japan.

pibrentasvir
glecaprevir
chronic hepatitis
National Center for Child Health and Development /ID# 225293
 (6.3 away) Contact site
  • 1 views
  • 17 Sep, 2021
  • +34 other locations